Integral Health Asset Management’s Hologic HOLX Stock Holding History

Integral Health Asset Management’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$6.75M	–	92
2025 Q3	$6.75M	Sell	100,000 -25,000	-20%	-$1.66M	0.46%	64
2025 Q2	$8.14M	Buy	+125,000	New	+$7.49M	0.75%	38
2024 Q3	–	Sell	-50,000	Closed	-$3.71M	–	79
2024 Q2	$3.71M	Buy	+50,000	New	+$3.75M	0.35%	60
2024 Q1	–	Sell	-100,000	Closed	-$7.14M	–	87
2023 Q4	$7.14M	Sell	100,000 -25,000	-20%	-$1.74M	0.97%	46
2023 Q3	$8.68M	Sell	125,000 -50,000	-29%	-$3.78M	1.2%	34
2023 Q2	$14.2M	Buy	175,000 +100,000	+133%	+$8.17M	1.75%	15
2023 Q1	$6.05M	Buy	+75,000	New	+$6.04M	1.22%	37
2021 Q4	–	Sell	-120,000	Closed	-$8.86M	–	76
2021 Q3	$8.86M	Buy	+120,000	New	+$9M	2.55%	12
2020 Q4	–	Sell	-55,000	Closed	-$3.66M	–	73
2020 Q3	$3.66M	Buy	+55,000	New	+$3.48M	1.12%	31
2020 Q1	–	Sell	-30,000	Closed	-$1.57M	–	65
2019 Q4	$1.57M	Buy	+30,000	New	+$1.49M	0.61%	45

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Integral Health Asset Management's HOLX Position: Q4 2025 in Review

Integral Health Asset Management sold out of Hologic (HOLX) in Q4 2025, closing a stake of 100,000 shares — an estimated $6.75M sold.

Integral Health Asset Management first reported a position in HOLX in Q4 2019 and held it in 10 quarters. The position peaked at $14.2M in Q2 2023. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

Integral Health Asset Management reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
Integral Health Asset Management sold 100,000 Hologic shares in Q4 2025, an estimated $6.75M.
Integral Health Asset Management first reported a position in Hologic in Q4 2019 and held it in 10 quarters.
Integral Health Asset Management's Hologic position peaked at $14.2M in Q2 2023.
749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Integral Health Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.